Norris Medicines recalls toxic syrups, says only sold in India
India's Norris Medicines (NORI.BO) has recalled a cough syrup and an allergy syrup that the country's federal drugs regulator had found to be toxic, its managing director said on Friday, adding that the products had only been sold in India. Key Points
ReutersCentral regulator to now give NOC for export of new, unapproved medicines after safety concerns
India’s exports of pharmaceuticals during 2022-23 was valued at $25.4 billion with a growth of almost 3.25 percent over the previous financial year, according to Pharmexcil. Key Points
ThePrintDrug regulator calls for cancelling licence of firm related to Uzbek deaths
Marion Biotech’s Dok-1 cough syrups allegedly led to the deaths of the children in December 2022. Noida police on Friday arrested three officials of the company on the basis of an FIR lodged by the Central Drugs Standard Control Organization (CDSCO). | Latest News India Key Points
Hindustan Times